홈
마켓
차트 & 아이디어
Algo
뉴스
스토어
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
히트맵
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
F
FBT
First Trust Amex Biotech Index Fund
222.7
4
USD
+0.66%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.66%
월간 변동
+10.29%
6달 변화
+4.86%
년간 변동율
+39.95%
이전 종가
221.2
8
Open
222.8
1
저가
222.7
4
High
222.8
9
양
16
마켓
US ETFs
FBT
전체 차트 열기
Full chart
개요
모든 보유 자산
히트맵
주요 보유 종목
Market Value
Shares
Weight %
Exact Sciences Corp
68.348 M
672.986 K
5.147%
ILMN
Illumina Inc
54.872 M
418.360 K
4.132%
REGN
Regeneron Pharmaceuticals Inc
53.672 M
69.535 K
4.041%
KRYS
Krystal Biotech Inc
53.340 M
216.354 K
4.016%
NTRA
Natera Inc
53.137 M
231.948 K
4.001%
BRKR
Bruker Corp
52.427 M
1.113 M
3.948%
ACAD
ACADIA Pharmaceuticals Inc
52.277 M
1.957 M
3.936%
VCYT
Veracyte Inc
47.498 M
1.128 M
3.577%
BIIB
Biogen Inc
47.143 M
267.876 K
3.550%
INCY
Incyte Corp
46.276 M
468.520 K
3.485%
EXEL
Exelixis Inc
45.123 M
1.030 M
3.398%
WAT
Waters Corp
45.055 M
118.620 K
3.393%
BMRN
BioMarin Pharmaceutical Inc
44.597 M
750.418 K
3.358%
RGEN
Repligen Corp
44.296 M
270.328 K
3.335%
AMGN
Amgen Inc
44.293 M
135.325 K
3.335%
VRTX
Vertex Pharmaceuticals Inc
43.648 M
96.277 K
3.287%
UTHR
United Therapeutics Corp
43.479 M
89.234 K
3.274%
MRNA
Moderna Inc
43.155 M
1.463 M
3.250%
MTD
Mettler-Toledo International I
42.977 M
30.826 K
3.236%
ARGX
Argenx SE
41.432 M
49.268 K
3.120%
1
2
뉴스
First Quarter Earnings: Sharpening Sector Divergence
3 Reasons To Stick With Growth Stocks In Rotating Markets
Seeking Innovation Beyond Tech? Insight On Healthcare Stocks
Makary's Successor Faces Tough Task Managing FDA Amid Budget Cuts
What's The Dominant Trend In Earnings: AI Or Geopolitics?
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?
Medical Technology Stocks: Innovation Endures As Valuations Reset
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)?
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil